Assignee
EMERGEX VACCINES HOLDING LTD
GB·11 granted patents·6 pending applications·3 citations·filing 2015–2023
Top patents by PatentIndex Score
17 records- 0184US11690904B2MHC class I associated peptides for prevention and treatment of multiple flavi virusEMERGEX VACCINES HOLDING LTD·Filed 2019·Granted Jul 4, 2023·1 cites·20 claims
- 0282US12178867B2MHC class i associated peptides for prevention and treatment of multiple flavi virusEMERGEX VACCINES HOLDING LTD·Filed 2023·Granted Dec 31, 2024·0 cites·20 claims
- 0378US11273216B2Universal influenza vaccine compositionsEMERGEX VACCINES HOLDING LTD·Filed 2018·Granted Mar 15, 2022·1 cites·12 claims
- 0478US2024050548A1Mhc class i associated peptides for prevention and treatment of multiple flavi virusEMERGEX VACCINES HOLDING LTD·Filed 2023·Application pending·0 cites
- 0575US11931407B2MHC class I associated peptides for prevention and treatment of zika virusEMERGEX VACCINES HOLDING LTD·Filed 2022·Granted Mar 19, 2024·0 cites·20 claims
- 0672US10117922B2Dengue virus specific multiple HLA binding T cell epitopes for the use of universal vaccine developmentEMERGEX VACCINES HOLDING LTD·Filed 2015·Granted Nov 6, 2018·1 cites·6 claims
- 0771US11191828B2MHC class I associated hepatitis B peptidesEMERGEX VACCINES HOLDING LTD·Filed 2018·Granted Dec 7, 2021·0 cites·4 claims
- 0870US2022054631A1MHC Class I Associated Hepatitis B PeptidesEMERGEX VACCINES HOLDING LTD·Filed 2021·Application pending·0 cites
- 0961US10155036B2MHC class I associated peptides for prevention and treatment of hepatitis B virus infectionEMERGEX VACCINES HOLDING LTD·Filed 2015·Granted Dec 18, 2018·0 cites·8 claims
- 1059US11426457B2MHC class I associated peptides for prevention and treatment of zika virusEMERGEX VACCINES HOLDING LTD·Filed 2018·Granted Aug 30, 2022·0 cites·5 claims
- 1156US2024269264A1Human coronavirus 229e derived peptidesEMERGEX VACCINES HOLDING LTD·Filed 2022·Application pending·0 cites
- 1254US2025101065A1Reverse peptides from coronavirus for immunogenic purposesEMERGEX VACCINES HOLDING LTD·Filed 2022·Application pending·0 cites
- 1351US11344614B2Pharmaceutical compositions comprising dengue virus-specific multiple HLA-binding T cell epitopesEMERGEX VACCINES HOLDING LTD·Filed 2018·Granted May 31, 2022·0 cites·1 claims
- 1449US12409215B2Vaccine compositionsEMERGEX VACCINES HOLDING LTD·Filed 2019·Granted Sep 9, 2025·0 cites·18 claims
- 1548US12156909B2Reverse peptide vaccineEMERGEX VACCINES HOLDING LTD·Filed 2019·Granted Dec 3, 2024·0 cites·21 claims
- 1645US2021283237A1Vaccine compositionsEMERGEX VACCINES HOLDING LTD·Filed 2019·Application pending·0 cites
- 1743US2023203103A1Diagnosis, prevention and treatment of coronavirus infectionEMERGEX VACCINES HOLDING LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EMERGEX VACCINES HOLDING LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →